Genetico

Genetico is one of the largest laboratory and production complexes of international level in Russia, built according to GLP standards, providing a wide range of medical and genetic services for both doctors and patients. The center provides comprehensive genetic diagnostics of inherited diseases and reproductive disorders.
P/E
Net profit
P/B
Book value
Debts
Net debt
Yield
Growth potential

Genetico balance sheet

Report period2019 2020 2021 2022 2023 Q3 24
End date of the reporting period
Capitalization, ₽
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Genetico cash flows

Report period2019 2020 2021 2022 2023 Q3 24 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
EPS

Genetico multipliers

Report period2019 2020 2021 2022 2023 Q3 24 TTM
P/E
E/P
P/B
P/S
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Genetico profitability

Report period2019 2020 2021 2022 2023 Q3 24 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Genetico assets
Genetico cash flows

Genetico shares

TickerNameTypeNominal valueISINPrice
GECO:RMGeneticoCommon shareRUB 0.01RU000A105BN4RUB 26.3

Genetico bonds

NameIssue sizePriceYield
GENETICO BO-01 (RUB)145,000 pcs.96.5%11.19%
Share capital structure of Genetico
Genetico news
15.11.2024
Genetico's board of directors has set the offering price of the additional shares at ₽34 per paper. Company is placing 7 million shares to be purchased by parent Artgen Biotech and HSCI Ventures. Raised funds will be used to repay Genetico's bond issue.
Source: {source} pictogram e-disclosure.ru
Pictogram next
30.10.2024
Genetico's RAS loss for 9 months of 2024 was ₽5.4 million, down 3.4 times from ₽18.3 million in the previous year. Revenue increased 18.7% to ₽297 million against ₽250.3 million a year earlier.
Source: {source} pictogram e-disclosure.ru
Pictogram next
16.10.2024
Genetico shareholders have approved an additional ₽240 million to repay a bond issue. Securities will be purchased by the parent Artgen Biotech.
Source: {source} pictogram e-disclosure.ru
Pictogram next
16.09.2024
Genetico will issue an additional ₽240 million to repay a bond issue. Securities will be purchased by the parent Artgen Biotech.
Source: {source} pictogram artgen.ru
Pictogram next
All Genetico news
General information
Company nameGenetico
Tags#ipo2023
SectorHealth Care / Health Care Equipment & Services / Health Care Providers & Services / Health Care Facilities
Business address143026, g. Moskva, territoriya Skolkovo innovacionnogo centra, Bulvar Bolshoy, dom 42, stroenie 1, etazh 1 pom. 334 rab. mes. 52
Mailing address119333, g. Moskva, ul. Gubkina, d. 3, korp.1
CEOIsaev Artur Aleksandrovich
Phone+7 495 646-80-76
Websiteinvestors.genetico.ru
Information disclosuree-disclosure.ru